Form 15-12G - Securities registration termination [Section 12(g)]:
SEC Accession No. 0001193125-25-059362
Filing Date
2025-03-20
Accepted
2025-03-20 17:01:35
Documents
1
Effectiveness Date
2025-03-20

Document Format Files

Seq Description Document Type Size
1 15-12G d927463d1512g.htm 15-12G 10111
  Complete submission text file 0001193125-25-059362.txt   11230
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

EIN.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 15-12G | Act: 34 | File No.: 001-37813 | Film No.: 25757339
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)